|Articles|November 1, 1997

Ongoing digitizer slump affects Lumisys Q3 results

Ongoing digitizer slump affects Lumisys Q3 resultsA slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its

Ongoing digitizer slump affects Lumisys Q3 results

A slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its third quarter.

Although sales showed signs of rebounding, revenues for the period (end-September) were $6 million, compared with $5.9 million for the third quarter in 1996. Net income was $616,000 compared with $817,000 in the same period last year.

The company also reported that the low-cost computed radiography reader it is developing for the medical market is on track for a late-1999 launch (PNN 5/97). Engineers at CompuRad will also be working on the CR project, once that company's acquisition is finalized.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 3rd, 2026

Emerging Research Insights and New Advances in Neuroradiology

Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.

October 2nd, 2026

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.

October 1st, 2026

Current Perspectives on Integrating AI into Radiology

In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.

October 1st, 2026

Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA

Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?

September 30th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1

In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.

September 30th, 2026

Top Five Radiology Content in September 2026

Catch up on the most-well viewed radiology content in September 2026.

September 30th, 2026

FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection

The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.

September 29th, 2026

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer

For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.

Ongoing digitizer slump affects Lumisys Q3 results